AZ_Cap

AZ_Cap Updated 

RingCentral has broken out of its two-year consolidation phase, supported by a historically low multiple and steady growth in revenue and profit. I’m holding a substantial position in my portfolio, as the breakout's strength will be confirmed (or challenged) by next week’s earnings report. That said, my long-term price target remains firm.

AZ_Cap Updated 

Alt season is likely approaching! We're currently hitting resistance on the intermediate-term trend line, making a correction in BTC dominance seem reasonable. If more institutional money starts shifting from BTC to ETH ETFs, it could trigger a surge in major altcoins, creating retail FOMO. Retail investors typically have a higher risk appetite than institutions,...

AZ_Cap Updated 

Palantir's stock is facing several risks that could justify a short position. Its overvaluation is evident, trading at a P/E ratio of around 247 after a 150% surge in 2024, implying that future growth is heavily priced in; if the company doesn't meet these expectations, a sharp correction could occur​. Insider selling over the past 90 days has raised doubts about...

AZ_Cap Updated 

Shorting Novo Nordisk may be considered due to potential overvaluation, rising competition in diabetes and obesity markets, supply chain challenges, and risks from patent expirations. Regulatory hurdles, slower demand in key regions, and macroeconomic factors like healthcare budgets and inflation could further impact growth. However, thorough analysis is...

AZ_Cap Updated 

Sea limited broke the biggest resistance since the stock's inception, as well as the year long trend line, the stock chart looks incredibly bullish. The stock does not have a strong resistance till $ 200, hence a strong earning would really accelerate the price action like back to the 2021 days.

AZ_Cap Updated 

Fundamentals: Ouster has its propiertery innovative and cost-effective digital lidar technology, which sets it apart from competitors relying on more expensive, legacy systems. The company’s diversified approach across industries—such as automotive, robotics, smart cities, and industrial automation—minimizes sector-specific risks and opens multiple revenue...

AZ_Cap

A hypothetical five wave combining with the Elliot waves would hit around $60 for Bilibili at the end of 2025.

AZ_Cap

Helium has strong fundamentals, with tangible products and projects positioning it as a potential leader in the DePIN space. On the technical front, it appears the ABC corrective waves are complete. If HNT experiences another set of ascending waves with a similar magnitude as before, the price could easily reach $11.

AZ_Cap

BTC recently broke through resistance, and from the RSI perspective, the oversold signal has dissipated, with BTC recovering from the recent dip back to the moving average RSI. The fourth wave correction appears fully absorbed by the market, positioning BTC for the fifth wave. The conservative target price is set at $100k, aligning with the 1.618 Fibonacci level.

AZ_Cap Updated 

Nio looking at $7 before hitting any technical resistance, first profit target $7, and next profit target $9. NIO is severely undervalued compared to Lucid, Tesla, Rivian, trading at 1.2x PS.

AZ_Cap

Nio had a volatile month like most other Chinese stock, but they are still fully broken out of the downward trend line, and are now testing the support. Need to pay close attention to the movement around the support line.

AZ_Cap

Bilibili has seen significant volatility, largely influenced by anticipation of China's upcoming "Stimulus" package, which has generated some artificial noise. However, looking at the company's fundamentals, the next quarterly earnings report is expected to mark its first profitable season. With a young, loyal user base and the recent launch of ad and e-commerce...

AZ_Cap

The macro environment are favoring the defensive stocks with the on-going + more geopolitical risk, and it was supported by breaking the 20 year trend line for RTX. I would be cautious of entering a big position, but it seems to have more steams left.

AZ_Cap

NVAX had some headwinds news with the small set back on the 2nd stage clinical trial. The 15% drop landed the NVAX at the bottom of the trend line, a confirmed break below low (below 10$ for 2+ trading days) would be a strong sell signal, or a potential rebounded to the up trendline with more support of debunking the allegation.

AZ_Cap

The Novo Nordisk head-and-shoulders pattern is taking shape, with a target price of $97. While the long-term outlook remains bullish, the hype around weight loss drugs is cooling off due to increasing competition and growing awareness of potential unknown side effects.

AZ_Cap

Sunnova has broken out of a 4-year downward trend, marking a significant move to confirm the breakout. The next major resistance level is at $13.70, presenting a potential 30% upside until reaching that point.

AZ_Cap

ChargePoint had a rough earnings season, no doubt. However, its improvements in profitability show promise, suggesting it could approach break-even within the next 1-2 years. Given its unique business model—especially compared to other EV charging infrastructure companies—ChargePoint's significant and growing software segment stands out. Could we soon see a shift...

AZ_Cap

Amer sports is on a strong upwards trend where it got tested more than 4 times, the first up trend gap has formed and there could be another one in the next 1-2 months to accelerate the price action, maybe next earning? price target 17$